Dudediligence.

IDEXX Laboratories, Inc

IDXXNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$975.5MSep ’24$954.3MDec ’24$998.4MMar ’25$1.11BJun ’25$1.11BSep ’25$1.09BDec ’25$1.14BMar ’26$1.22BJun ’26
Net income, by quarter
$232.8MSep ’24$216.1MDec ’24$242.7MMar ’25$294.0MJun ’25$274.6MSep ’25$248.2MDec ’25$278.4MMar ’26$338.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.22B$3.37B$3.66B$3.90B$4.30B
Gross profit$1.89B$2.00B$2.19B$2.38B$2.66B
Operating income$932.0M$898.8M$1.10B$1.13B$1.36B
Net income$744.8M$679.1M$845.0M$887.9M$1.06B
Operating cash flow$755.5M$543.0M$906.5M$929.0M$1.18B
Free cash flow$636.0M$394.1M$772.9M$808.1M$1.06B
Cash$144.5M$112.5M$453.9M$288.3M$180.1M
Debt$850.2M$769.4M$697.9M$617.6M$449.8M
Shares outstanding84.6M82.9M83.0M81.6M79.7M